ROCHE HOLDING LTD - 25 Jan 2023 Form 4 Insider Report for Jasper Therapeutics, Inc. (JSPR)

Role: 10%+ Owner
Signature: ROCHE FINANCE LTD, By: /s/ Beat Kraehenmann, Authorized Signatory
Issuer symbol: JSPR
Transactions as of: 25 Jan 2023
Net transactions value: -$141,750
Form type: 4
Filing time: 26 Jan 2023, 16:49:09 UTC
Previous filing: 04 Nov 2021
Next filing: 07 Nov 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	JSPR	Voting Common Stock	Sale	$141,750	-75,000	-1.6%	$1.89	4,549,606	25 Jan 2023	See Footnote	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents shares held by Roche Finance Ltd ("Roche Finance"). Roche Finance is a wholly owned subsidiary of Roche Holding Ltd ("Roche Holding"), a Swiss corporation whose shares are traded on the SIX Swiss Exchange. Roche Holding is the indirect beneficial owner of these securities of the Issuer. This Form 4 shall not be deemed an admission that any reporting person or other person is a beneficial owner of any securities of the Issuer for any purpose, other than the securities reported in this Form 4.

Content

Represents shares held by Roche Finance Ltd ("Roche Finance"). Roche Finance is a wholly owned subsidiary of Roche Holding Ltd ("Roche Holding"), a Swiss corporation whose shares are traded on the SIX Swiss Exchange. Roche Holding is the indirect beneficial owner of these securities of the Issuer. This Form 4 shall not be deemed an admission that any reporting person or other person is a beneficial owner of any securities of the Issuer for any purpose, other than the securities reported in this Form 4.